Research Article| Volume 57, P31-40, January 2023

Download started.


Retrospective validation of acute heart failure risk stratification in the emergency department


      • Patients with acute HF are frequently hospitalized when they present to the ED.
      • EHMRG estimates 7-day mortality for patients with acute HF specifically in the ED.
      • EHMRG stratifies patients into risk groups to augment clinical decisions.
      • Lower risk patients with acute HF may be considered for discharge or care in EDOUs.



      Heart Failure (HF) is a primary diagnosis for hospital admission from the Emergency Department (ED), although not all patients require hospitalization. The Emergency Heart Failure Mortality Risk Grade (EHMRG) estimates 7-day mortality in patients with acute HF in ED settings, but further validation is needed in the United States (US).


      To validate EHMRG scores by risk-stratifying patients with acute HF in a large tertiary healthcare center in the US and analyze outcome measures to determine if EHMRG risk scores safely identify low-risk groups that may be discharged or managed in ED observation units (EDOUs).


      A retrospective cohort analysis of 304 patients with acute HF presenting to an ED at a large, tertiary healthcare center was completed. EHMRG scores were calculated to stratify patients according to published thresholds. Mortality and major adverse cardiac event (MACE) rates were analyzed.


      No deaths occurred in very low and low-risk EHMRG groups at 7 days post discharge. 30-day mortality was significantly less in the lower risk groups (3.1%) when compared to all other patients (11.1%). MACE rates at 30 days in the very low risk group (15%) were significantly less when compared to all other patients (31.3%). Hospitalizations occurred in 23.4% of patients in lower risk groups.


      ED risk stratification with EHMRG differentiates high-risk patients requiring hospitalization from lower risk patients who can be safely managed in alternative settings with good outcomes. Data supports improved pathways for patients with acute HF during a time of high hospital volumes.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart & Lung: The Journal of Cardiopulmonary and Acute Care
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Heart Disease and Stroke Statistics—2021 Update | Circulation. Accessed March 7, 2021.

        • Yancy Clyde W.
        • Jessup M.
        • Bozkurt B.
        • et al.
        ACCF/AHA guideline for the management of heart failure.
        Circulation. 2013; 128: e240-e327
        • Collins S.P.
        • Storrow A.B.
        Moving toward comprehensive acute heart failure risk assessment in the emergency department: the importance of self-care and shared decision making.
        JACC Heart Fail. 2013; 1: 273-280
        • Storrow A.B.
        • Jenkins C.A.
        • Self W.H.
        • et al.
        The burden of acute heart failure on U.S. emergency departments.
        JACC Heart Fail. 2014; 2: 269-277
      2. Weiss A.J. Overview of emergency department visits in the United States, 2011.:13.

        • Hollenberg Steven M.
        • Warner Stevenson L.
        • Ahmad T.
        • et al.
        ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure.
        J Am Coll Cardiol. 2019; 74: 1966-2011
        • Lee Douglas S.
        • Lee Jacques S.
        • Schull Michael J.
        • et al.
        Prospective validation of the emergency heart failure mortality risk grade for acute heart failure.
        Circulation. 2019; 139: 1146-1156
        • Ho E.C.
        • Schull M.J.
        • Lee D.S.
        The challenge of heart failure discharge from the emergency department.
        Curr Heart Fail Rep. 2012; 9: 252-259
        • Lee D.S.
        • Stitt A.
        • Austin P.C.
        • et al.
        Prediction of heart failure mortality in emergent care.
        Ann Intern Med. 2012; 156: 767-775
        • Harris P.A.
        • Taylor R.
        • Thielke R.
        • Payne J.
        • Gonzalez N.
        • Conde J.G.
        Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support.
        J Biomed Inform. 2009; 42: 377-381
        • Harris P.A.
        • Taylor R.
        • Minor B.L.
        • et al.
        The REDCap consortium: building an international community of software platform partners.
        J Biomed Inform. 2019; 95103208
      3. Mayo Clinic. Using high sensitivity cardiac troponin T (hs-cTnT). Published online June 2018.

        • Miró Ò.
        • Levy P.D.
        • Möckel M.
        • et al.
        Disposition of emergency department patients diagnosed with acute heart failure: an international emergency medicine perspective.
        Eur J Emerg Med Off J Eur Soc Emerg Med. 2017; 24: 2-12
        • Collins S.P.
        • Pang P.S.
        • Fonarow G.C.
        • Yancy C.W.
        • Bonow R.O.
        • Gheorghiade M.
        Is hospital admission for heart failure really necessary?: The role of the emergency department and observation unit in preventing hospitalization and rehospitalization.
        J Am Coll Cardiol. 2013; 61: 121-126
      4. Find Healthcare Providers: Compare Care Near You | Medicare. Accessed March 18, 2021.

        • Januzzi J.L.
        • Mahler S.A.
        • Christenson R.H.
        • et al.
        Recommendations for institutions transitioning to high-sensitivity troponin testing: JACC scientific expert panel.
        J Am Coll Cardiol. 2019; 73: 1059-1077
        • Kontos M.C.
        • Turlington J.S.
        High-sensitivity troponins in cardiovascular disease.
        Curr Cardiol Rep. 2020; 22: 30